Cargando…
PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression
OBJECTIVE: We aimed to determine the function of pyrroline-5-carboxylate reductase 1 (PYCR1) on progression of papillary renal cell carcinoma (PRCC) and related mechanism. METHODS: The TCGA database provided us expression profiles of PYCR1 and overall survival rates. Small interfering RNA (siRNA) wa...
Autores principales: | Wang, Qiu-Li, Liu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698050/ https://www.ncbi.nlm.nih.gov/pubmed/31428683 http://dx.doi.org/10.1515/med-2019-0066 |
Ejemplares similares
-
The clinical significance of PYCR1 expression in renal cell carcinoma
por: Weijin, Fu, et al.
Publicado: (2019) -
Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma
por: Xu, Yanzhen, et al.
Publicado: (2021) -
PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress
por: Kuo, Mei-Ling, et al.
Publicado: (2016) -
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
por: Xu, Xianglai, et al.
Publicado: (2023) -
PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Wang, Huanyu, et al.
Publicado: (2022)